Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Letrozole Plus Erlotinib in Post-menopausal Women With ER/PR+ Metastatic Breast Cancer
NCT00611715Phase 2Terminated
- Sponsor
- Vanderbilt-Ingram Cancer Center
- Start
- Nov 2003
- Primary completion
- Dec 2008
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of erlotinib in breast cancer, sponsored by Vanderbilt-Ingram Cancer Center. Started Nov 2003; status: terminated.
02
Drugs
erlotinib
03
Conditions
breast cancer
Beyond the preview
Go deeper on NCT00611715.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00611715.